Over the last couple of decades, the paradigm of premature immunosenescence in systemic
autoimmune diseases such as rheumatoid arthritis (RA) has emerged1, 2. The theory of …

Antiphospholipid syndrome (APS) is defined as the presence of venous or arterial
thromboses, and/or recurrent miscarriage, with evidence of antiphospholipid antibodies …

Термин «фетальный аллотрансплантат» отражает иммунологический статус
фетальных тканей в материнском организме. Нарушение процессов формирования …

While much is understood concerning the clinical features of patients with antiphospholipid
syndrome (APS), many issues remain. The proper designation of patients with “definite” APS …

Catastrophic antiphospholipid syndrome (CAPS, Asherson's syndrome) is an unusual form
of antiphospholipid syndrome (APS) characterized by multi-organ failure and high mortality …

Progression to an angiogenic state is a critical event in tumor development, yet few patient
characteristics have been identified that can be mechanistically linked to this transition …

目的; 探讨抗β2-糖蛋白Ⅰ 抗体(anti-β2—GP Ⅰ antibody) 与反复自然流产(RSA) 的关系. 方法:
采用酶联免疫吸附法检测81 例RSA 患者和39 例正常妇女血清中anti-β2-GP Ⅰ 的水平. 结果 …

Antiphospholipid syndrome (APS) has been defined as a clinical and laboratory entity.
Laboratory criteria include the presence of anticardiolipin antibodies (aCL) and/or lupus …

Introduction 3. Immunology of atherosclerosis 3.1. Oxidative modification of LDL 3.2. Lesion
development and composition 3.3. Immune mechanisms in atherosclerosis 4. Antibodies in …

目的: 探讨重组人β2 糖蛋白1 (hrβ2-GP1) 对抗磷脂抗体综合征(APS) 患者血清诱导内皮细胞系
产生细胞间黏附分子-1 (ICAM-1) 的影响. 方法: 应用pQE30 表达载体表达hrβ2-GP1, Western …